Metropolitan Life Insurance CO Macrogenics Inc Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

46 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$4.82 - $7.24 $1,956 - $2,939	-406 Reduced 11.0%	3,285 $23,000
Q4 2022 Jun 14, 2023	BUY	$3.34 - $6.98 $1,356 - $2,833	406 Added 12.36%	3,691 $24.8 Million
Q3 2022 Jun 14, 2023	BUY	$3.01 - $5.22 $1,222 - $2,119	406 Added 12.36%	3,691 $12.8 Million
Q3 2022 Mar 30, 2023	BUY	$3.01 - $5.22 $9,433 - $16,359	3,134 Added 562.66%	3,691 $11,000
Q3 2022 Nov 14, 2022	BUY	$3.01 - $5.22 $9,433 - $16,359	3,134 Added 562.66%	3,691 $13,000
Q2 2022 Jun 20, 2023	SELL	$2.25 - $9.99 $6,138 - $27,252	-2,728 Reduced 83.04%	557 $1,000
Q2 2022 Mar 30, 2023	SELL	$2.25 - $9.99 $7,465 - $33,146	-3,318 Reduced 85.63%	557 $1,000
Q2 2022 Aug 11, 2022	SELL	$2.25 - $9.99 $7,465 - $33,146	-3,318 Reduced 85.63%	557 $2,000
Q1 2022 Jun 20, 2023	BUY	$8.12 - $16.9 $4,790 - $9,971	590 Added 17.96%	3,875 $34,000
Q1 2022 Mar 30, 2023	SELL	$8.12 - $16.9 $99,608 - $207,312	-12,267 Reduced 75.99%	3,875 $34,000
Q1 2022 May 12, 2022	SELL	$8.12 - $16.9 $99,608 - $207,312	-12,267 Reduced 75.99%	3,875 $34,000
Q4 2021 Jun 21, 2023	BUY	$15.91 - $21.88 $204,554 - $281,311	12,857 Added 391.39%	16,142 $259,000
Q3 2021 Jun 21, 2023	BUY	$19.74 - $28.7 $253,797 - $368,995	12,857 Added 391.39%	16,142 $338,000
Q2 2021 Jun 21, 2023	BUY	$20.49 - $35.63 $263,439 - $458,094	12,857 Added 391.39%	16,142 $433,000
Q2 2021 Mar 30, 2023	BUY	$20.49 - $35.63 $23,133 - $40,226	1,129 Added 7.52%	16,142 $433,000
Q2 2021 Aug 16, 2021	BUY	$20.49 - $35.63 $330,442 - $574,605	16,127 Added 107513.33%	16,142 $434,000
Q1 2021 Jun 26, 2023	BUY	$18.99 - $33.2 $222,714 - $389,369	11,728 Added 357.02%	15,013 $478 Million
Q1 2021 Mar 30, 2023	SELL	$18.99 - $33.2 $8,564 - $14,973	-451 Reduced 2.92%	15,013 $478,000
Q1 2021 May 14, 2021	SELL	$18.99 - $33.2 $293,376 - $512,906	-15,449 Reduced 99.9%	15 $478,000
Q4 2020 Jun 22, 2023	BUY	$19.41 - $26.0 $236,394 - $316,654	12,179 Added 370.75%	15,464 $353,000
Q3 2020 Jun 26, 2023	BUY	$24.69 - $31.6 $300,699 - $384,856	12,179 Added 370.75%	15,464 $389,000
Q2 2020 Jun 26, 2023	BUY	$5.2 - $29.12 $63,330 - $354,652	12,179 Added 370.75%	15,464 $431,000
Q2 2020 Mar 30, 2023	BUY	$5.2 - $29.12 $34,694 - $194,288	6,672 Added 75.89%	15,464 $431,000
Q2 2020 Aug 14, 2020	BUY	$5.2 - $29.12 $34,694 - $194,288	6,672 Added 75.89%	15,464 $432,000
Q1 2020 Jul 12, 2023	BUY	$4.28 - $12.11 $23,569 - $66,689	5,507 Added 167.64%	8,792 $51,000
Q1 2020 Mar 30, 2023	SELL	$4.28 - $12.11 $26,373 - $74,621	-6,162 Reduced 41.21%	8,792 $51,000
Q1 2020 May 15, 2020	SELL	$4.28 - $12.11 $26,373 - $74,621	-6,162 Reduced 41.21%	8,792 $51,000
Q4 2019 Jul 12, 2023	BUY	$7.95 - $12.27 $92,768 - $143,178	11,669 Added 355.22%	14,954 $162,000
Q4 2019 Mar 30, 2023	SELL	$7.95 - $12.27 $10,374 - $16,012	-1,305 Reduced 8.03%	14,954 $162,000
Q4 2019 Feb 14, 2020	SELL	$7.95 - $12.27 $10,374 - $16,012	-1,305 Reduced 8.03%	14,954 $163,000
Q3 2019 Jul 12, 2023	BUY	$12.44 - $17.48 $161,396 - $226,785	12,974 Added 394.95%	16,259 $207,000
Q3 2019 Mar 30, 2023	BUY	$12.44 - $17.48 $38,327 - $53,855	3,081 Added 23.38%	16,259 $207,000
Q3 2019 Nov 14, 2019	BUY	$12.44 - $17.48 $38,327 - $53,855	3,081 Added 23.38%	16,259 $207,000
Q2 2019 Jul 12, 2023	BUY	$14.51 - $19.71 $153,124 - $207,999	10,553 Added 321.25%	13,838 $234,000
Q1 2019 Jul 13, 2023	BUY	$11.11 - $25.6 $109,911 - $253,260	9,893 Added 301.16%	13,178 $236,000
Q1 2019 Mar 30, 2023	BUY	$11.11 - $25.6 $105,400 - $242,867	9,487 Added 257.03%	13,178 $236,000
Q1 2019 May 16, 2019	SELL	$11.11 - $25.6 $126,976 - $292,582	-11,429 Reduced 46.45%	13,178 $236,000
Q1 2019 May 15, 2019	BUY	$11.11 - $25.6 $126,976 - $292,582	11,429 Added 86.73%	24,607 $310,000
Q4 2018 Jul 13, 2023	BUY	$11.75 - $21.42 $116,242 - $211,908	9,893 Added 301.16%	13,178 $167,000
Q4 2018 Feb 14, 2019	BUY	$11.75 - $21.42 $120,931 - $220,454	10,292 Added 356.62%	13,178 $167,000
Q3 2018 Jul 13, 2023	BUY	$19.26 - $23.46 $190,539 - $232,089	9,893 Added 301.16%	13,178 $283 Million
Q3 2018 Nov 14, 2018	SELL	$19.26 - $23.46 $198,223 - $241,450	-10,292 Reduced 78.1%	2,886 $62,000
Q2 2018 Aug 15, 2018	BUY	$19.78 - $24.67 $65,728 - $81,978	3,323 Added 33.72%	13,178 $0
Q1 2018 May 15, 2018	SELL	$18.89 - $32.46 $35,494 - $60,992	-1,879 Reduced 16.01%	9,855 $0
Q4 2017 Feb 15, 2018	SELL	$16.19 - $20.3 $169,833 - $212,947	-10,490 Reduced 47.2%	11,734 $223,000
Q2 2017 Aug 14, 2017	BUY	N/A	22,224	22,224 $389,000

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

Bellevue Group Ag Kuesnacht, V8

9.93M
Shares

$32.4 Million
0.55% of portfolio
Armistice Capital, LLC New York, NY

6.26M
Shares

$20.4 Million
0.34% of portfolio
Black Rock Inc. New York, NY

5.4M
Shares

$17.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.36M
Shares

$14.2 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.54M
Shares

$11.5 Million
0.01% of portfolio

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account